Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Xiaobo Mao, Michael T. Ou, Senthilkumar S. Karuppagounder, et al.
Science (2016) Vol. 353, Iss. 6307
Open Access | Times Cited: 619

Showing 1-25 of 619 citing articles:

Parkinson disease
Werner Poewe, Klaus Seppi, Caroline M. Tanner, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 3800
Extracellular Vesicles: Unique Intercellular Delivery Vehicles
Sybren L. N. Maas, Xandra O. Breakefield, Alissa M. Weaver
Trends in Cell Biology (2016) Vol. 27, Iss. 3, pp. 172-188
Open Access | Times Cited: 1253
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1065
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
Sangjune Kim, Seung‐Hwan Kwon, Tae‐In Kam, et al.
Neuron (2019) Vol. 103, Iss. 4, pp. 627-641.e7
Open Access | Times Cited: 1054
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin, Linping Xu, Ming Yi, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 960
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mark P. Mattson, Thiruma V. Arumugam
Cell Metabolism (2018) Vol. 27, Iss. 6, pp. 1176-1199
Open Access | Times Cited: 932
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Seung Pil Yun, Tae‐In Kam, Nikhil Panicker, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 931-938
Open Access | Times Cited: 914
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
A new era for understanding amyloid structures and disease
M.G. Iadanza, Matthew P. Jackson, Eric W. Hewitt, et al.
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 12, pp. 755-773
Closed Access | Times Cited: 853
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews, Ariel E. Marciscano, Charles G. Drake, et al.
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 80-96
Open Access | Times Cited: 773
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong, Dimitri Krainc
Nature Medicine (2017) Vol. 23, Iss. 2, pp. 1-13
Open Access | Times Cited: 733
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang, Miguel F. Sanmamed, Ila Datar, et al.
Cell (2018) Vol. 176, Iss. 1-2, pp. 334-347.e12
Open Access | Times Cited: 711
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
David Sulzer, Roy N. Alcalay, Francesca Garretti, et al.
Nature (2017) Vol. 546, Iss. 7660, pp. 656-661
Open Access | Times Cited: 689
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 582
Protein transmission in neurodegenerative disease
Chao Peng, John Q. Trojanowski, Virginia M.‐Y. Lee
Nature Reviews Neurology (2020) Vol. 16, Iss. 4, pp. 199-212
Open Access | Times Cited: 472
Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease
Donghoon Kim, Je Min Yoo, Heehong Hwang, et al.
Nature Nanotechnology (2018) Vol. 13, Iss. 9, pp. 812-818
Open Access | Times Cited: 391
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Tae‐In Kam, Xiaobo Mao, Hyejin Park, et al.
Science (2018) Vol. 362, Iss. 6414
Open Access | Times Cited: 384
Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Min Guo, Jian Wang, Yanxin Zhao, et al.
Brain (2020) Vol. 143, Iss. 5, pp. 1476-1497
Open Access | Times Cited: 374
Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
Insup Choi, Yuanxi Zhang, Steven P. Seegobin, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 373
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
LAG-3: from molecular functions to clinical applications
Takumi Maruhashi, Daisuke Sugiura, Il‐mi Okazaki, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001014-e001014
Open Access | Times Cited: 360
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Mathias Jucker, Lary C. Walker
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1341-1349
Open Access | Times Cited: 355
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 334
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang, Alberto J. Espay
Movement Disorders (2018) Vol. 33, Iss. 5, pp. 660-677
Open Access | Times Cited: 319
Alpha-synuclein oligomers: a new hope
Nora Bengoa‐Vergniory, Rosalind F. Roberts, Richard Wade‐Martins, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 6, pp. 819-838
Open Access | Times Cited: 316
Page 1 - Next Page

Scroll to top